陶里索洛®的抗疹活性,葡萄葡萄多烯酸提取物
Carla Zannella1, Annalisa Chianese1, Giuseppe Annunziata2
1Department of Experimental Medicine, University of Campania "Luigi Vanvitelli", 80138 Naples, Italy.
Microorganisms
|June 15, 2023
概括
一种新的葡萄葡萄汁提取物Taurisolo®在阻止单纯疹病毒 (HSV) 感染方面表现有前途. 这种营养药物配方可能为预防和治疗疹病变提供一种新的局部治疗方法.
科学领域:
- 病毒学 病毒学
- 自然产品化学 自然产品化学
- 皮肤病学 皮肤病学
背景情况:
- 单纯疹病毒 (HSV) 感染很普遍,导致常见的和罕见的严重并发症.
- 目前的治疗方法,如阿西克洛维尔,面临挑战,因为长期使用可能会产生耐药性.
- 需要新的抗病毒化合物来解决现有疗法的局限性.
研究的目的:
- 为了评估Taurisolo®的抗HSV潜力,Taurisolo®是一种基于多的新型营养药物配方,来源于葡萄末.
- 研究Taurisolo®对HSV-1和HSV-2感染的作用机制.
主要方法:
- 用HSV-1和HSV-2的斑块测试来评估抗病毒活性.
- 通过实时PCR,传输电子显微镜 (TEM) 和光显微镜探索了作用机制.
- 当Taurisolo®与病毒添加时和当病毒进行预处理时,都进行了测试.
主要成果:
- 陶里索洛®显示出对HSV-1和HSV-2的显著抑制活性.
- 该配方有效地阻断了病毒感染,表明在感染的早期阶段有作用.
- 证据表明Taurisolo®在早期感染阶段对细胞和直接对病毒起作用.
结论:
- 葡萄末提取物Taurisolo®对HSV-1和HSV-2具有强大的抗病毒活性.
- 这些发现支持Taurisolo®作为预防和治疗疹病变的局部药物的潜力.
- 这项研究强调了一种用于管理疹感染的新型天然化合物.
相关概念视频
01:28Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
523
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
523
01:28Antimicrobial Effectiveness
98
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
98
01:19Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
218
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
218